These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8837300)

  • 1. Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer.
    Nagy J; Curry GW; Hillan KJ; McKay IC; Mallon E; Purushotham AD; George WD
    Surg Oncol; 1996 Feb; 5(1):15-21. PubMed ID: 8837300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression.
    Beviglia L; Matsumoto K; Lin CS; Ziober BL; Kramer RH
    Int J Cancer; 1997 Jun; 74(3):301-9. PubMed ID: 9221809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist.
    Martin TA; Parr C; Davies G; Watkins G; Lane J; Matsumoto K; Nakamura T; Mansel RE; Jiang WG
    Carcinogenesis; 2003 Aug; 24(8):1317-23. PubMed ID: 12807719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
    Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
    Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: alternative receptors.
    Wilson SE; Weng J; Chwang EL; Gollahon L; Leitch AM; Shay JW
    Cell Mol Biol Res; 1994; 40(4):337-50. PubMed ID: 7866434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue.
    Lindemann K; Resau J; Nährig J; Kort E; Leeser B; Annecke K; Welk A; Schäfer J; Vande Woude GF; Lengyel E; Harbeck N
    Histopathology; 2007 Jul; 51(1):54-62. PubMed ID: 17593080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET.
    Jiang WG; Grimshaw D; Martin TA; Davies G; Parr C; Watkins G; Lane J; Abounader R; Laterra J; Mansel RE
    Clin Cancer Res; 2003 Sep; 9(11):4274-81. PubMed ID: 14519655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells.
    Parr C; Jiang WG
    Int J Oncol; 2001 Oct; 19(4):857-63. PubMed ID: 11562767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma.
    Tolnay E; Kuhnen C; Wiethege T; König JE; Voss B; Müller KM
    J Cancer Res Clin Oncol; 1998; 124(6):291-6. PubMed ID: 9692834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
    Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
    EXS; 1993; 65():311-28. PubMed ID: 8380739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts.
    Rygaard K; Nakamura T; Spang-Thomsen M
    Br J Cancer; 1993 Jan; 67(1):37-46. PubMed ID: 7678980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).
    Moriyama T; Kataoka H; Koono M; Wakisaka S
    Int J Mol Med; 1999 May; 3(5):531-6. PubMed ID: 10202187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
    Abounader R; Ranganathan S; Lal B; Fielding K; Book A; Dietz H; Burger P; Laterra J
    J Natl Cancer Inst; 1999 Sep; 91(18):1548-56. PubMed ID: 10491431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-met proto-oncogene expression in benign and malignant human prostate tissues.
    Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW
    J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and loss of heterozygosity of c-met proto-oncogene in primary breast cancer.
    Nagy J; Clark JS; Cooke A; Campbell AM; Connor JM; Purushotham AD; George WD
    J Surg Oncol; 1995 Oct; 60(2):95-9. PubMed ID: 7564388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering.
    Bardelli A; Ponzetto C; Comoglio PM
    J Biotechnol; 1994 Sep; 37(2):109-22. PubMed ID: 7765452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met.
    Weidner KM; Hartmann G; Sachs M; Birchmeier W
    Am J Respir Cell Mol Biol; 1993 Mar; 8(3):229-37. PubMed ID: 8383506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
    Halaban R; Rubin JS; Funasaka Y; Cobb M; Boulton T; Faletto D; Rosen E; Chan A; Yoko K; White W
    Oncogene; 1992 Nov; 7(11):2195-206. PubMed ID: 1331934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HGF/SF in angiogenesis.
    Rosen EM; Lamszus K; Laterra J; Polverini PJ; Rubin JS; Goldberg ID
    Ciba Found Symp; 1997; 212():215-26; discussion 227-9. PubMed ID: 9524773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M; Li Z; Marreli M; Nguyen BT; Park M; Wong K
    Cell Growth Differ; 1997 Apr; 8(4):451-62. PubMed ID: 9101091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.